Passwords play a huge role in how you stay safe online. They protect your accounts, devices and money. Still, many people pick logins that criminals can guess in seconds. The latest NordPass report ...

Python has become one of the most popular programming languages out there, particularly for beginners and those new to the hacker/maker world. Unfortunately, while it’s easy to get something up and ...

Recursion Pharmaceuticals (RXRX) is drawing renewed attention after the appointment of Najat Khan as CEO and news of a narrowing net loss, both viewed as signals of improving execution. Investors also ...

Eloquence, the art of expressing ideas with clarity and grace, profoundly impacts audiences and remains memorable. This valuable tool, rooted in the Latin "eloqui," enables precise communication of ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Trump’s latest speech included a confusing word mix-up that quickly caught the internet’s attention. Memes and jokes spread rapidly following the viral moment. Coach John Beam dies after being shot on ...

Shohei Ohtani once again proved to be the best player in MLB on Friday, closing out the National League Championship Series for the Los Angeles Dodgers in style, hitting three home runs and racking up ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

RXRX stock looks like a deep-value growth bet at just $5 and change. Though the technology is exciting, I’m not rushing into shares just yet. Nvidia made early investors rich, but there is a new class ...